Retained Earnings
Guardant Health Retained Earnings decreased by 3.7% to -$3.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.2%, from -$2.67B to -$3.11B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows a downward trend with a 37.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
A positive and growing balance indicates profitable operations and reinvestment, while a negative balance (accumulated deficit) is common for early-stage biotech firms investing heavily in R&D.
Detailed definition
This represents the cumulative net income earned by the company since inception, minus any dividends paid to shareholder...
Peer comparison
Early-stage and growth-stage biotech companies often show negative retained earnings due to sustained investment in clinical trials.
retained_earningsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$809.39M | -$916.91M | -$1.01B | -$1.13B | -$1.36B | -$1.52B | -$1.66B | -$1.8B | -$1.87B | -$1.95B | -$2.14B | -$2.26B | -$2.36B | -$2.47B | -$2.58B | -$2.67B | -$2.77B | -$2.87B | -$2.99B | -$3.11B |
| QoQ Change | — | -13.3% | -9.9% | -12.2% | -20.3% | -11.9% | -9.2% | -8.0% | -4.1% | -4.6% | -9.6% | -5.4% | -4.5% | -4.6% | -4.5% | -3.7% | -3.7% | -3.3% | -4.5% | -3.7% |
| YoY Change | — | — | — | — | -68.1% | -66.0% | -65.0% | -58.8% | -37.4% | -28.4% | -28.8% | -25.7% | -26.3% | -26.2% | -20.4% | -18.5% | -17.5% | -16.2% | -16.1% | -16.2% |
Retained Earnings at Other Companies
Frequently Asked Questions
- What is Guardant Health's retained earnings?
- Guardant Health (GH) reported retained earnings of -$3.11B in Q1 2026.
- How has Guardant Health's retained earnings changed year-over-year?
- Guardant Health's retained earnings decreased by 16.2% year-over-year, from -$2.67B to -$3.11B.
- What is the long-term trend for Guardant Health's retained earnings?
- Over 5 years (2020 to 2025), Guardant Health's retained earnings has grown at a 37.6% compound annual growth rate (CAGR), from -$606.59M to -$2.99B.
- What does retained earnings mean?
- The total accumulated profit kept in the business since inception.